| Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence G Tisone, G Orlando, A Cardillo, G Palmieri, TM Manzia, L Baiocchi, ... Journal of hepatology 44 (4), 702-709, 2006 | 175 | 2006 |
| Saline contrast echocardiography in patients with hepatopulmonary syndrome awaiting liver transplantation I Lenci, A Alvior, TM Manzia, L Toti, J Neuberger, R Steeds Journal of the American Society of Echocardiography 22 (1), 89-94, 2009 | 75 | 2009 |
| Marginal donors in liver transplantation G Tisone, TM Manzia, S Zazza, NDL Carino, C Ciceroni, I De Luca, L Toti, ... Transplantation proceedings 36 (3), 525-526, 2004 | 70 | 2004 |
| Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: two case reports TM Manzia, R Angelico, L Toti, A Cillis, P Ciano, G Orlando, A Anselmo, ... Transplantation proceedings 43 (4), 1181-1183, 2011 | 65 | 2011 |
| Liver transplantation in the presence of portal vein thrombosis: report from a single center G Orlando, L De Luca, L Toti, S Zazza, M Angelico, CU Casciani, ... Transplantation proceedings 36 (1), 199-202, 2004 | 59 | 2004 |
| Reduction in bile leaks following adult split liver transplant using a fibrin-collagen sponge: a pilot study L Toti, M Attia, TM Manzia, I Lenci, B Gunson, JAC Buckels, DF Mirza, ... Digestive and Liver Disease 42 (3), 205-209, 2010 | 55 | 2010 |
| De novo malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature TM Manzia, R Angelico, C Gazia, I Lenci, M Milana, OT Ademoyero, ... World Journal of Gastroenterology 25 (35), 5356, 2019 | 54 | 2019 |
| One-shot versus multidose perioperative antibiotic prophylaxis after kidney transplantation: a randomized, controlled clinical trial G Orlando, TM Manzia, R Sorge, G Iaria, R Angelico, D Sforza, L Toti, ... Surgery 157 (1), 104-110, 2015 | 50 | 2015 |
| Liver transplantation performed in a SARS‐CoV‐2 positive hospitalized recipient using a SARS‐CoV‐2 infected donor TM Manzia, C Gazia, I Lenci, R Angelico, L Toti, A Monaco, A Anselmo, ... American Journal of Transplantation 21 (7), 2600-2604, 2021 | 43 | 2021 |
| Use of mycophenolate mofetil in liver transplantation: a literature review TM Manzia, NDL Carino, G Orlando, L Toti, L De Luca, D D’Andria, ... Transplantation proceedings 37 (6), 2616-2617, 2005 | 41 | 2005 |
| Machine perfusions in liver transplantation: the evidence‐based position paper of the Italian society of organ and tissue transplantation D Ghinolfi, Q Lai, D Dondossola, R De Carlis, M Zanierato, D Patrono, ... Liver Transplantation 26 (10), 1298-1315, 2020 | 39 | 2020 |
| The management of immunosuppression in kidney transplant recipients with COVID-19 disease: an update and systematic review of the literature R Angelico, F Blasi, TM Manzia, L Toti, G Tisone, R Cacciola Medicina 57 (5), 435, 2021 | 37 | 2021 |
| TUDCA prevents cholestasis and canalicular damage induced by ischemia‐reperfusion injury in the rat, modulating PKCα–ezrin pathway L Baiocchi, G Tisone, MA Russo, C Longhi, G Palmieri, A Volpe, ... Transplant international 21 (8), 792-800, 2008 | 36 | 2008 |
| Successful treatment of systemic de novo sarcoidosis with cyclosporine discontinuation and provision of rapamune after liver transplantation. TM Manzia, MI Bellini, L Corona, L Toti, S Fratoni, A Cillis, G Orlando, ... Transplant International 24 (8), 2011 | 34 | 2011 |
| Benign disease and unexpected histological findings after pancreaticoduodenectomy: the role of endoscopic ultrasound fine needle aspiration TM Manzia, L Toti, I Lenci, M Attia, L Tariciotti, SR Bramhall, JAC Buckels, ... The Annals of The Royal College of Surgeons of England 92 (4), 295-301, 2010 | 34 | 2010 |
| The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10‐year follow‐up TM Manzia, R Angelico, L Baiocchi, L Toti, P Ciano, G Palmieri, ... Transplant International 26 (3), 259-266, 2013 | 33 | 2013 |
| Survival after the diagnosis of de novo malignancy in liver transplant recipients M Taborelli, P Piselli, GM Ettorre, U Baccarani, P Burra, A Lauro, ... International Journal of Cancer 144 (2), 232-239, 2019 | 32 | 2019 |
| Long‐term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C TM Manzia, R Angelico, L Toti, MI Bellini, D Sforza, G Palmieri, G Orlando, ... Transplant International 24 (5), 461-468, 2011 | 30 | 2011 |
| Risk of virus and non‐virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985–2014 M Taborelli, P Piselli, GM Ettorre, A Lauro, L Galatioto, U Baccarani, ... International journal of cancer 143 (7), 1588-1594, 2018 | 29 | 2018 |
| Complete hepatitis B virus prophylaxis withdrawal in hepatitis B surface antigen–positive liver transplant recipients after longterm minimal immunosuppression I Lenci, L Baiocchi, L Tariciotti, D Di Paolo, M Milana, F Santopaolo, ... Liver Transplantation 22 (9), 1205-1213, 2016 | 27 | 2016 |
